Prostate Artery Embolization for Benign Prostatic Hyperplasia: Rationale for the Use of N-Butyl Cyanoacrylate Glue as an Embolic Agent
- PMID: 35441241
- DOI: 10.1007/s00270-022-03144-9
Prostate Artery Embolization for Benign Prostatic Hyperplasia: Rationale for the Use of N-Butyl Cyanoacrylate Glue as an Embolic Agent
Comment on
-
Prostatic Artery Embolization for Benign Prostatic Obstruction: Single-Centre Retrospective Study Comparing Microspheres Versus n-Butyl Cyanoacrylate.Cardiovasc Intervent Radiol. 2022 Jun;45(6):814-823. doi: 10.1007/s00270-022-03069-3. Epub 2022 Mar 9. Cardiovasc Intervent Radiol. 2022. PMID: 35266024
References
-
- Salet E, Crombe A, Grenier N, Marcelin C, Lebras Y, Jambon E, et al. Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol. 2022; Ahead of Print.
-
- Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281:289–300. - DOI
-
- Cornelis FH, Bilhim T, Hacking N, Sapoval M, Tapping CR, Carnevale FC. CIRSE standards of practice on prostatic artery embolisation. Cardiovasc Intervent Radiol. 2020;43:176–85. - DOI
-
- Loffroy R, Guillen K, Salet E, Marcelin C, Comby PO, Midulla M, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles? J Clin Med. 2021;10:3161. - DOI
-
- Loffroy R, Desmyttere AS, Mouillot T, Pellegrinelli J, Facy O, Drouilllard A, et al. Ten-year experience with arterial embolization for peptic ulcer bleeding: n-butyl cyanoacrylate glue versus other embolic agents. Eur Radiol. 2021;31:3015–26. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical